85 - Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel

Meehan, D., Pang, Y., Fisher, P. et al. (8 more authors) (2023) 85 - Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel. In: Lung Cancer. 21st Annual British Thoracic Oncology Group Conference 2023, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier , S37-S37.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 Elsevier. This is an author produced version of a paper subsequently published in Lung Cancer. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Dates:
  • Published (online): 24 April 2023
  • Published: April 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jul 2025 15:50
Last Modified: 11 Jul 2025 21:41
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: 10.1016/S0169-5002(23)00512-3
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)